Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $4.09 Million - $4.8 Million
3,993 New
3,993 $4.2 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $2.78 Million - $3.16 Million
3,582 Added 367.38%
4,557 $4 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $675,138 - $823,260
975 New
975 $802,000
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $2.92 Million - $3.55 Million
4,294 New
4,294 $3.53 Million
Q4 2019

Feb 13, 2020

SELL
$274.13 - $376.51 $4.36 Million - $5.99 Million
-15,900 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $4.35 Million - $5.06 Million
15,900 New
15,900 $4.41 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $77.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.